Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

$1.76

+$0.01 (+0.57%)

Nov 2, 2026, 3:41 PM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024
Cash & Equivalents	11.54M	3.08M	5.14M	5.75M	3.3M	4.16M	4.62M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	33K	27K	156K	38K	4K	n/a
Total Current Assets	11.81M	3.5M	5.17M	5.98M	3.54M	4.44M	5M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	250K	n/a	n/a	n/a	n/a
Total Assets	11.81M	3.5M	5.42M	5.98M	3.54M	4.44M	5M
Account Payables	683K	850K	470K	496K	158K	55K	72K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	169K	n/a	21K	n/a	n/a	n/a	1K
Total Current Liabilities	873K	1.01M	605K	682K	296K	185K	289K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	250K	n/a	n/a	n/a	n/a
Total Liabilities	873K	1.01M	855K	682K	296K	185K	289K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Book Value	10.94M	2.49M	4.57M	5.3M	3.25M	4.25M	4.71M
Book Value Per Share	0.23	0.05	0.10	0.03	0.02	0.02	0.02
Common Stock	5K	5K	5K	19K	18K	18K	16K
Retained Earnings	-103.56M	-102.18M	-99.64M	-98.14M	-96.71M	-95.7M	-90.65M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	10.94M	2.49M	4.57M	5.3M	3.25M	4.25M	4.71M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a